Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.57 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.53 |
| ▸ | GNPAT | O15228 | 1/20 | 0.53 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | ECE1 | P42892 | 1/20 | 0.51 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30099583 | 0.98 | GNPAT (0.56) | ERAP2LNPEPFOLH1NAALAD2MMP2 | |
| SCHEMBL30099620 | 0.98 | GNPAT (0.56) | ERAP2LNPEPFOLH1NAALAD2MMP2 | |
| SCHEMBL30099615 | 0.98 | GNPAT (0.56) | ERAP2LNPEPFOLH1NAALAD2MMP2 | |
| SCHEMBL29774691 | 0.98 | GNPAT (0.56) | ERAP2LNPEPFOLH1NAALAD2MMP2 | |
| SCHEMBL29774693 | 0.98 | GNPAT (0.56) | ERAP2LNPEPFOLH1NAALAD2MMP2 | |
| SCHEMBL30740082 | 0.97 | NAALAD2 (0.56) | ERAP2LNPEPFOLH1NAALAD2MMP2 | |
| SCHEMBL29763124 | 0.95 | BACE1 (0.53) | ERAP2LNPEPFOLH1NAALAD2GNPAT | |
| SCHEMBL29763133 | 0.95 | BACE1 (0.53) | ERAP2LNPEPFOLH1NAALAD2GNPAT | |
| SCHEMBL29630324 | 0.95 | ERAP2 (0.52) | ERAP2LNPEPFOLH1NAALAD2MMP2 | |
| SCHEMBL29630365 | 0.94 | ERAP2 (0.62) | ERAP2LNPEPMMP2GNPATECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054602-A1 | PROTEIN FOR THE SEROLOGICAL DETECTION OF STREPTOCOCCUS EQUI SUBSPECIES EQUI EXPOSURE OR INFECTION | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2025-03-13 | — | — | WO | claimed |
| CN-117106716-A | Method for culturing cells and kit and device for use in the method | 朱诺治疗学有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-116656605-A | Methods, kits and devices for expanding cell populations | 朱诺治疗有限公司 | 2023-08-29 | — | — | CN | claimed |
| WO-2023017115-A1 | FRACTIONATION OF CELLS BASED ON A MARKER PROTEIN | IBA LIFESCIENCES GMBH (DE) | 2023-02-16 | — | — | WO | claimed |
| US-20220204935-A1 | MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-06-30 | — | — | US | claimed |
| US-12516099-B2 | Processes for generating engineered cells and compositions thereof | JUNO THERAPEUTICS, INC. (US) | 2026-01-06 | — | — | US | disclosed |
| US-20250237628-A1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-07-24 | — | — | US | disclosed |
| WO-2025083196-A1 | A METHOD OF MANUFACTURING A CELLULAR THERAPY PRODUCT AND RESPECTIVE KITS AND DEVICES | TQ THERAPEUTICS GMBH (DE) | 2025-04-24 | — | — | WO | disclosed |
| CN-119242611-A | Thermostable mismatch endonuclease variants | 宝生物工程株式会社 | 2025-01-03 | — | — | CN | disclosed |
| CN-115210380-B | Thermostable mismatch endonuclease variants | 宝生物工程株式会社 | 2024-10-15 | — | — | CN | disclosed |
| CN-118765282-A | Anti-NGF antibodies and uses thereof | 因外泰克斯股份有限公司 | 2024-10-11 | — | — | CN | disclosed |
| EP-4441247-A1 | LUCIFERASE-INTERCALATING DYE CONJUGATES FOR RATIOMETRIC NUCLEIC ACID DETECTION | Technische Universiteit Eindhoven (NL) | 2024-10-09 | — | — | EP | disclosed |
| US-20230181641-A1 | PROCESS FOR PRODUCING DONOR-BATCHED CELLS EXPRESSING A RECOMBINANT RECEPTOR | JUNO THERAPEUTICS, INC. (US) | 2023-06-15 | — | — | US | disclosed |
| WO-2023096493-A1 | LUCIFERASE-INTERCALATING DYE CONJUGATES FOR RATIOMETRIC NUCLEIC ACID DETECTION | TECHNISCHE UNIVERSITEIT EINDHOVEN (NL) | 2023-06-01 | — | — | WO | disclosed |
| CN-108431210-B | Method for culturing cells and kit and device for use in the method | 朱诺治疗学有限公司 | 2023-05-23 | — | — | CN | disclosed |
| EP-4165064-A2 | DOCK TAG SYSTEM | GlaxoSmithKline Biologicals S.A. (BE) | 2023-04-19 | — | — | EP | disclosed |
| WO-2023017115-A1 | FRACTIONATION OF CELLS BASED ON A MARKER PROTEIN | IBA LIFESCIENCES GMBH (DE) | 2023-02-16 | — | — | WO | disclosed |
| WO-2022234009-A2 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2022-11-10 | — | — | WO | disclosed |
| EP-4051402-A1 | CELL SELECTION AND/OR STIMULATION DEVICES AND METHODS OF USE | Juno Therapeutics GmbH (DE) | 2022-09-07 | — | — | EP | disclosed |
| US-20220204935-A1 | MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF | FRED HUTCHINSON CANCER RESEARCH CENTER (US) | 2022-06-30 | — | — | US | disclosed |